Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-24

Clinical Trial Update: IUS Predicts Guselkumab Efficacy in Patients With Moderate to Severe Crohn's Disease:a Prospective Study

View source ↗

Summary

A prospective study is evaluating whether intestinal ultrasound can predict guselkumab efficacy in moderate-to-severe Crohn's disease. The trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guselkumab (guselkumab)

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Crohn's Disease, Guselkumab | Status: RECRUITING